Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Surgery of the Primary Tumour With Few or Absent Symptoms in Patients With Synchronous Unresectable Metastases of Colorectal Cancer, a Randomized Phase III Study. A Study of the Dutch Colorectal Cancer Group (DCCG)

NCT01606098 is registered in ClinicalTrials.gov with Dutch Colorectal Cancer Group as lead sponsor.

NCT NCT01606098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01606098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Surgery of the Primary Tumour With Few or Absent Symptoms in Patients With Synchronous Unresectable Metastases of Colorectal Cancer, a Randomized Phase III Study. A Study of the Dutch Colorectal Cancer Group (DCCG)
Lead sponsor
Dutch Colorectal Cancer Group
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2012
Completion date
December 31, 2022
Enrollment
206 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, primary tumour, rectal cancer